Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
981studies shown
Showing 205-216 of 981
Drug study icon
RecruitingNCT07483294

Cerebellum-based Imaging Neural Markers for Antipsychotic Response

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In United States
SchizophreniaDrugA study involving a medication or substance.From 15 Years to 40 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT03388606

Characterization and Treatment of Adolescent Depression

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In United States
DepressionBehavioralFrom 11 Years to 25 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
Behavioral study icon
RecruitingNCT05427123

Children's Bipolar Network Treatment study I

This study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.

In United States
BipolarityBehavioralFrom 9 Years to 19 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Bipolarity
Device study icon
RecruitingNCT05276050

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In United States
SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT05656469

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

This study is recruiting. It focuses on anxiety and currently lists participation information in Germany, the Netherlands, Romania, Serbia, Spain, the United Kingdom, and the United States.

In United States
Anxiety, SchizophreniaBehavioralFrom 16 Years to 70 Years
Countries
United States, United Kingdom, Germany, ...
Sponsor
Parnassia Groep
Condition
Anxiety, Schizophrenia
Drug study icon
RecruitingNCT05824728

AGB101 for Schizophrenia

This study is recruiting in the United States. It is testing AGB101 for Schizophrenia.

In United States
SchizophreniaDrugFrom 40 Years to 85 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Schizophrenia